Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-86093

high

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute a…

Vendor / product: Ibm — db2

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute arbitrary commands on Db2 clients due to a stack-based buffer overflow that improperly copies user-controlled data into a fixed-size stack buffer without bounds checking.

CVSS
7.5
7.5 (CVSS v3.1)
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
Severity source: NVD CVSS v3.1 (psirt@us.ibm.com)
Timeline (UTC)
Published: 2026-09-10 22:17
Modified: 2026-09-14 20:10
NVD status: Analyzed
Last synced 1 day ago
Verified against the source API 2026-10-27 06:52 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

ibm / db2 ≥11.5 ≤11.5.9, ≥12.1.0 ≤12.1.5

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

Vendor advisory: https://www.ibm.com/support/pages/node/7286993

References

Data sources

NVD CVE API 2.0 — fetched 2026-10-27 06:52 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores

Related CVEs